Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference
17 nov. 2023 08h00 HE
|
Benitec Biopharma Inc.
HAYWARD, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update
13 nov. 2023 08h00 HE
|
Benitec Biopharma Inc.
Benitec Biopharma, a genetic medicines company, releases updates on OPMD program and other corporate and financial updates.
Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update
21 sept. 2023 08h00 HE
|
Benitec Biopharma Inc.
Received FDA Clearance of the Investigational New Drug (IND) application for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (OPMD)-Related Dysphagia 15 subjects enrolled in the OPMD...
Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023
25 juil. 2023 13h00 HE
|
Benitec Biopharma Inc.
HAYWARD, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy
26 juin 2023 08h00 HE
|
Benitec Biopharma Inc.
HAYWARD, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update
15 mai 2023 08h00 HE
|
Benitec Biopharma Inc.
HAYWARD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma to Present at the OPMD International Conference
08 mai 2023 08h05 HE
|
Benitec Biopharma Inc.
HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma to Present at the JMP Securities Life Sciences Conference
08 mai 2023 08h00 HE
|
Benitec Biopharma Inc.
HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...
Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update
13 févr. 2023 08h00 HE
|
Benitec Biopharma Inc.
HAYWARD, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel...